Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

HealthRX vs PepHaūs

By GLP-1 ScorecardUpdated

HealthRXFactor scores not reassessed.
Site position #34

Lower score

PepHaūsFactor scores not reassessed.
Site position #25

Higher score

Score comparison

PepHaūs has the higher recorded score — 82.7/100 to 77.5/100.

PepHaūs grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Compare monthly billing with prepaid commitments, then confirm renewal pricing and supply.

Before you choose

Before comparing the headline prices, the HealthRX review and the PepHaūs review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.

If neither one fits, HealthRX vs Precision Telemed and Heva Health vs PepHaūs compare each of them with another graded program, and the list of alternatives to HealthRX ranks the programs closest to HealthRX on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueHealthRX +3
85
82
Dose & formulationPepHaūs +16
64
80
Clinical oversightHealthRX +3
87
84
Labs & monitoringEven
82
82
FulfillmentEven
86
86
Contract termsPepHaūs +42
43
85
HealthRX · top barPepHaūs · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricHealthRXPepHaūs
WeighScore77.5/10082.7/100
GradeC+B−
Site position#34#25
Semaglutide$39 first month, then $125/month on a 3-month plan ($115 on 6 months, $97 on 12); month to month $109 first month, then $139/month$169 monthly; prepaid plans available (advertised)
Tirzepatide$39 first month, then $219/month on a 3-month plan ($179 on 6 months, $159 on 12); month to month $109 first month, then $239/month$239 monthly; prepaid plans available (advertised)
CoverageAll 50 states claimed; subject to clinical eligibilityClaims all 50 states plus DC; treatment eligibility requires confirmation
Brand-name accessNot confirmedNot confirmed
Oral / sublingualNot confirmedNot confirmed
HealthRX

Site position #34 · C+

Factor scores not reassessed.

Strengths

  • First payment and recurring monthly charge shown together for every plan
  • Medication if prescribed, review, instructions and overnight shipping included; no separate GLP-1 membership fee stated
  • A month-to-month option carries no minimum term
  • Full refund promised if clinical approval is declined

What to consider

  • On 3-, 6- and 12-month plans the remaining monthly payments stay due after an early cancellation
  • Assigned medical practice and dispensing pharmacy not named on reviewed public pages
  • Refund promises for unshipped doses need reconciliation with restrictions after dispensing
  • Injection supplies, clinical response time and monitoring cadence unconfirmed
PepHaūs

Site position #25 · B−

Factor scores not reassessed.

Strengths

  • Publishes monthly and prepaid plan amounts
  • Names provider and pharmacy partners

What to consider

  • Price-lock wording needs reconciling with renewal terms
  • Actual supply and longer-plan shipments remain unverified
  • Independent license and certification status remain unverified

Featured provider

HealthRX

Factor scores not reassessed.

HealthRX scores 77.5/100 (C+). HealthRX advertises a $39 first month on three-, six- and twelve-month injection plans, with a higher month-to-month option; a plan's remaining monthly payments stay due if you cancel early.

Commercial relationships affect this placement. The score comparison above is separate.

Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.

← Back to the scorecard